IFP Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50
| Closed | -$1K | – | 4649 |
|
|
2021
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 3150 |
|
|
2021
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 3154 |
|
|
2021
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 5129 |
|
|
2021
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 4946 |
|
|
2020
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 4703 |
|
|
2020
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 4496 |
|
|
2020
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 4260 |
|
|
2020
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 4112 |
|
|
2019
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 3994 |
|
|
2019
Q3 | $0 | Buy |
+50
| New | – | ﹤0.01% | 3908 |
|
|
2019
Q1 | – | Sell |
-50
| Closed | – | – | 3830 |
|
|
2018
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 3993 |
|
|
2018
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 4079 |
|
|
2018
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 4144 |
|
|
2018
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 3864 |
|
|
2017
Q4 | $0 | Sell |
50
-50
| -50% | – | ﹤0.01% | 4220 |
|
|
2017
Q3 | $1K | Sell |
100
-150
| -60% | -$1.5K | ﹤0.01% | 3979 |
|
|
2017
Q2 | $3K | Hold |
250
| – | – | ﹤0.01% | 3636 |
|
|
2017
Q1 | $3K | Buy |
250
+150
| +150% | +$1.8K | ﹤0.01% | 3561 |
|
|
2016
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 3882 |
|
|
2016
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 3641 |
|
|
2016
Q2 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 3731 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$3K | – | 3854 |
|
|
2015
Q4 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 3242 |
|